Researchers explore the risks of cardiovascular and cerebrovascular events following vaccination against the COVID-19.
Study: Avoid Completion ALND for Abemaciclib Eligibility in Early Breast Cancer
The use of completion axillary lymph node dissection (cALND) to determine the need for adjuvant abemaciclib (Verzenio) among women with luminal estrogen receptor (ER)-positive, HER2-negative